In silico analyses also nominated candidate agents targeting this pathway, including resveratrol, ibuprofen, and danazol.<h4>Conclusion</h4>This study highlights the central role of NK-cell dysfunction in EM pathogenesis and proposes GNLY, PRF1, and ENTPD1 as potential molecular diagnostic biomarkers. This evidence concerns the gene PRF1 and erythema multiforme.